Skip to content
healthcare.dev

Imatinib Mesylate

NDC 62135-659, Imatinib Mesylate, tablet, film coated, from Chartwell RX, LLC.

Product NDC
62135-659
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208429
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-659 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE400 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
62135-659-306213506593030 TABLET, FILM COATED in 1 BOTTLE (62135-659-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/65b4d8a6-349d-4fb1-9818-dad6b4ad4fa1
  • NADAC price for package 62135065930

    GET /v1/drugs/nadac/62135065930

Use it

Look up 62135-659 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-659 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-659. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.